Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin for inflammatory markers in chronic renal disease
NCT00171262Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dyslipidemia comparing Fluvastatin with Placebo (2 arms). Primary endpoint: Change from baseline in serum inflammatory markers after 52 weeks. Started Aug 2004; status: completed.
02
Drugs
fluvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00171262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171262.